| PRSS16 expression based on | ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinoma
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaNote
Cancer stage information is not available for 8 samples.
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaNote
Patient race information is not available for 22 samples.
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaNote
Patient gender information is not available for 6 samples.
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaNote
Patient BMI information is not available for 54 samples.
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaNote
Patient age information is not available for 6 samples.
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaNote
Smoking status is not available for 19 samples.
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinoma
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaNote
Histological subtype information is not available for 5 samples.
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaBLCA subtypes: Robertson AG et al, Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2017 Oct 19;171(3):540-556.e25
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaNote
Nodal metastais status is not available for 6 samples and cancer in nearby lymph nodes cannot be measured (NX) in 36 samples.
| ||||||||||||||||||||||||||||||||||||||
BLCA : Bladder urothelial carcinomaTP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
| ||||||||||||||||||||||||||||||||||||||